Asaf Shiloni

Mr. Asaf Shiloni has more than 20 years of biotech executive experience and a deep knowledge of the cell therapy industry. Mr. Shiloni joins Kadimastem after an impressive 13 years at PeproTech Inc.

Based in California, he served as the company’s Vice President of Sales and Business Development.

PeproTech is the leading manufacturer of GMP Cytokines, vital components in all stem cell and cell therapy clinical trials. At PeproTech, Mr. Shiloni established collaborations and joint ventures with top US stem cell companies and leading research labs worldwide as well as led M&A processes.

Mr. Shiloni has extensive knowledge of the biotechnology market and close relations with the global investment community. He played a crucial role in making PeproTech an industry leader.

Prior to PeproTech, in 2007, Mr. Shiloni sold an Israeli biotech company CytoLab, that he co-founded and led for seven years. The Company specialized in the development and production of proteins, antibodies, and assays. Mr. Shiloni sold the company as a result of his successful business development activities there.

Before CytoLab, Mr. Shiloni served for three years as the CEO of a technology startup company ABN Global. Mr. Shiloni was hired by VC Delta Ventures, which had invested in the company. Mr. Shiloni lead the company, through his management and raised its capital to ongoing stable growth.

Mr. Shiloni holds a BA in Computer Information Systems and Business from The College of Management and an MBA from Tel Aviv University.